The Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ASP3652 in First-in-Human and Ascending Multiple Oral Dose Studies in Healthy Subjects
mediaposted on 2020-06-11, 08:49 authored by Masaomi Takizawa, Dirk Cerneus, Ingrid Michon, Sanne Rijnders, Desiree van der Heide, John Meijer, Matthias Stoelzel, Yuichiro Sato
Article full text
The above summary slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).
© The authors, CC-BY-NC 2020.